209 related articles for article (PubMed ID: 23242131)
1. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.
Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsukada K; Irimura T; Shibahara N; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
Oncol Rep; 2013 Mar; 29(3):975-82. PubMed ID: 23242131
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
[TBL] [Abstract][Full Text] [Related]
4. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
5. CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.
Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsuneyama K; Tsukada K; Irimura T; Shibahara N; Takasaki I; Inujima A; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
BMC Cancer; 2014 Dec; 14():949. PubMed ID: 25495942
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
Cullen R; Germanov E; Shimaoka T; Johnston B
J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease.
Yamauchi R; Tanaka M; Kume N; Minami M; Kawamoto T; Togi K; Shimaoka T; Takahashi S; Yamaguchi J; Nishina T; Kitaichi M; Komeda M; Manabe T; Yonehara S; Kita T
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):282-7. PubMed ID: 14699018
[TBL] [Abstract][Full Text] [Related]
8. Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesion.
Xu H; Xu W; Chu Y; Gong Y; Jiang Z; Xiong S
Infect Immun; 2005 Jul; 73(7):4007-16. PubMed ID: 15972488
[TBL] [Abstract][Full Text] [Related]
9. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
10. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
11. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
12. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
13. Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells.
Shimaoka T; Seino K; Kume N; Minami M; Nishime C; Suematsu M; Kita T; Taniguchi M; Matsushima K; Yonehara S
J Immunol; 2007 Dec; 179(12):8172-9. PubMed ID: 18056360
[TBL] [Abstract][Full Text] [Related]
14. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
Uza N; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Ueno S; Inoue S; Mikami S; Matsuura M; Shimaoka T; Kume N; Minami M; Yonehara S; Ikeuchi H; Chiba T
Gut; 2011 Nov; 60(11):1494-505. PubMed ID: 21471570
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
Zeng X; Zhou J; Xiong Z; Sun H; Yang W; Mok MTS; Wang J; Li J; Liu M; Tang W; Feng Y; Wang HK; Tsang SW; Chow KL; Yeung PC; Wong J; Lai PB; Chan AW; To KF; Chan SL; Xia Q; Xue J; Chen X; Yu J; Peng S; Sung JJ; Kuang M; Cheng AS
Cell Mol Immunol; 2021 Apr; 18(4):1005-1015. PubMed ID: 32879468
[TBL] [Abstract][Full Text] [Related]
17. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice.
Xu F; Ye YJ; Liu W; Kong M; He Y; Wang S
Scand J Gastroenterol; 2010 Jun; 45(6):707-13. PubMed ID: 20205622
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
20. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
